EP1551365A1

EP1551365A1 - Method for cosmetic body treatment to enhance the silhouette and to develop the female bust, and double-acting cosmetic composition therefor

Info

Publication number: EP1551365A1
Application number: EP03778395A
Authority: EP
Inventors: Etienne Soudant
Original assignee: INSTITUT JEANNE PIAUBERT
Current assignee: INSTITUT JEANNE PIAUBERT
Priority date: 2002-10-18
Filing date: 2003-10-15
Publication date: 2005-07-13
Also published as: FR2845912A1; RU2005115101A; AU2003285404A1; WO2004037221A1; FR2845912B1

Abstract

The invention concerns a method for cosmetic body treatment for enhancing the silhouette, characterized in that it consists in applying on a first zone whose volume is to be reduced (for instance the hips or the larger breast in the case of unproportioned busts), a product having lipolytic properties so as to bring about lipolysis of fats contained in the fat tissue cells concerned (hips, ) and on a second zone whose volume is to be increased (for example the breast/breasts), a product having lipogenetic properties so as to capture and fix, in said second zone, the fats released by the lipolytic product.

Description

Cosmetic body treatment method for improving the silhouette and development of the female bust, and binary cosmetic composition for its implementation.

The invention relates to a method of cosmetic treatment of the body to improve the silhouette, and / or to develop parts of the bust such as the breasts.

The subject of the invention is also a binary cosmetic composition or cosmetic complex consisting of two products, the joint use of which has the effect of increasing the volume of areas deemed to be too small or of too small size such as that of the breasts, while decreasing the volume of an area deemed too large, for example that of the hips.

The use of animal or plant derivative to cause tension in the skin of the bust is known (FR 2 296 425). The improvement made is however fleeting and rather mechanical or indirect through astringent effects or stimulation of local blood circulation.

The use of estrogenic hormones or phytoestrogens can be considered but poses a potential risk and is prohibited in cosmetics in certain countries (list of substances whose use in cosmetic products and personal care products is subject to ban on Annex II of the modified Cosmetic Directive 76/768 / EEC: estrogens and substances with effect).

Different organic compounds have been described (EP-0281647) but rather act as prostheses.

Fat synthesis promoters have been proposed (JP-11199499) to allow breast augmentation. This solution, which is better than the previous ones, however has the drawback of increasing the total fat mass of the person using it, which is not generally sought after. Efficiency is also low, and is reduced to the ability of breast tissue to synthesize this fat.

Research and experiment conducted by the author of the present invention have shown that the application, on the hips or other fatty areas of the lower part of the trunk or of the body, of a cosmetic product having the effect of locally stimulating lipolysis, associated with the application to the bust of a second cosmetic product having the effect of capturing and fixing the fats thus released, made it possible to obtain a noticeable development of the breasts without risk of side effect. In addition, the unsightly volume of the subject's hips is reduced by what the chest has gained, which is an additional advantage for the silhouette.

In addition to the development of breasts that are too modest in size, it has also been found that the binary composition according to the invention used according to the treatment method according to the invention, turns out to be of a definite advantage for solving problems such as those disproportionate breasts (one breast larger than the other). In this case the lipolytic product is applied to the larger breast and / or the hips and the other product to the smaller breast.

The present invention therefore relates to a method of cosmetic treatment of the body intended to improve the silhouette, characterized in that, on the one hand, it is applied to a first zone the volume of which is to be reduced (for example the hips or the breast the largest in the case of disproportionate breasts), a product with lipolytic properties in order to cause lipolysis of the fats contained in the adipocytes of the tissues concerned (such as the hips, ...), and, on the other hand, on a second zone, the volume of which is to be increased (for example the breast or breasts), a product endowed with lipogenetic properties so as to effect a capture and a fixation, in said second zone, of the fats released by the application of the lipolytic product.

More particularly, the present invention relates to a method of cosmetic treatment of the body intended to develop the bust, by applying on the one hand on an adipose zone of the body, a product endowed with lipolytic properties in order to cause a lipolysis of the fats contained in the adipocytes of the tissues of the zone concerned, and on the other hand, on the part or parts of the bust that l 'We wish to develop a product endowed with lipogenetic properties or an ability to capture the fats released by the application of the lipolytic product and to fix them in said parts of the bust.

The present invention also relates to a binary cosmetic composition or cosmetic complex for the implementation of this process, consisting on the one hand, of a product endowed with lipolytic properties intended to be applied to an adipose area of the body, and d 'on the other hand, of a product endowed with lipogenetic properties or an ability to capture fats and to fix them, intended to be applied on the part or parts of the bust which one wishes to develop.

The cosmetic complex according to the invention causes, on the one hand, lipolysis of the fats contained in the adipocytes of the tissues, preferably those of the hips (the presence of which is generally abundant at this level in women, and considered unsightly), and , on the other hand, a capture and fixation of the fats thus released, preferably at the breasts to increase the volume.

The product having lipolytic properties preferably, although in no way limiting, contains xanthines, and in particular caffeine or even alpha-tocopherol nicotinate, cola extract, carnitine, vitamin E and its acetate, blockers of alpha 2 receptor such as Ginkgo biloba, inhibitors of NPY receptors such as Enteromorpha compressa extract and any other lipolytic agent capable of releasing fat from adipocytes.

For these lipolytic agents, there may be mentioned:

oily plant extracts including: • Climbing ivy extract (Hedera helix), for example obtained by prolonged maceration of the leaves in propylene glycol;

• Arnica extract (Arnica montana L), for example obtained by maceration of arnica flower heads in glycol or in apricot kernel oil; • Rosemary extract (Rosmarinus officinalis N), for example obtained by prolonged maceration of the leaves in glycol or apricot kernel oil;

• Marigold extract (Calendule officinalis), for example obtained by prolonged maceration of flowers in glycol or apricot kernel oil;

• Sage extract (Salvia officinalis L), for example obtained by prolonged maceration of the leaves in glycol or apricot kernel oil;

• St. John's wort extract (Hypericum perforatum), for example obtained from flowers by maceration in neutral oil or in glycol;

• The extract of fragon, for example obtained from rhizomes of fragon (Ruscus aculeatus L), previously ground and extracted using an aqueous-alcoholic solution of an alcohol having 3 to 6 carbon atoms preferably in l using water-saturated n-butanol;

• Ulmaire extract (Filipendula ulmaria L), for example obtained by prolonged maceration of the whole plant in neutral oil or in isopropyl myristate; • Orthosiphon extract (Ortosifon stamincus benth), for example obtained by prolonged maceration of flower heads in neutral oil;

• The algae extract, for example obtained by prolonged maceration of the whole plant in an oxyethylenated oil

water-soluble plant extracts including: The water-soluble extract of algae, hydroglycolic extract obtained, by for example, by prolonged maceration of fronds in a solution of hydroglycolic extract;

• The water-soluble climbing ivy extract (Hedera helix) obtained, for example, by prolonged maceration of leaves and stems in a solution of hydroglycolic extract;

• The water-soluble birch extract (Betula alba) obtained, for example, by prolonged maceration of bark in a solution of hydroglycolic extract;

- hydro-alcoholic plant extracts, including the hydro-alcoholic extract of cola nuts (Cola Nipida), for example obtained by leaching seeds with alcohol;

The product intended to capture and fix the fats released after lipolysis, or “lipogenetic” product preferably contains, although in no way limiting, adenosine and / or vitamin A and / or Pro-retinol and / or Ginseng like any other another substance capable of retaining fat in breast adipocytes, among which there may be mentioned insulin-like substances or any factor of the IGF type (insulin growth factor).

The cosmetic complex according to the invention can be in different forms, in particular in the form of an oil-in-water emulsion.

(O / W) or water in oil (W / O) having the appearance of a cream or milk or in the form of a gel and also in the form of lipid vesicles consisting of ionic lipids (liposomes) or non-ionic lipids.

According to a first embodiment of the invention, the lipogenetic product is composed of:

- Acrylate C10-30 0.50 g

Adenosine 0.01 g

Ethoxydiglycol 5.00 g Ginseng extract 0.20 g

Alcohol 2.00 g

Retinyl palmitate 0.01 g

Carbomer 0.126 g - Butylene glycol 0.24 g

EDTA 0.005 g

Preservative 0.867 g

Macadamia oil 0.5 g

Hydrogenated lecithin 0.09 g - Cyclomethicone 0.20 g

TEA 99% 0.62 g

Soy extract 5.00 g

Dyes 0.0002 g

Demineralized water qs 100 g

According to a second embodiment, this product is composed of:

Carboxypolymethylene or Carboxylic polymer 0.40 g - Diethanolamine cetyl phosphate 1.50 g

Octyl dodecanol 5.50 g

Cetyl alcohol 1 g

Mineral oil 2.00 g

Stearic acid 1 g - Ethoxylated steryl alcohol (20E) 0.30 g

Keto-stearyl alcohol 1.80 g

Preservative 0.15 g

Macadamia oil 0.50 g

Triethanolamine 0.60 g - Cyclomethicone 12 g

Dimethicone copolyol 3.00 g

Phenyl Trimethicone 2.00 g Soy wisteria 5.00 g

Sepigel 305 1.00 g

Adenosine 0.20 g

Butylene glycol 6.00 g - Mica and titanium dioxide 1.00 g

Ginseng extract (Ginseng panax) 0.20 g

Climbing ivy extract (Hedera helix) 1 g

Demineralized water qs 100 g

Three other examples of embodiment are also set out below:

1 / O / W emulsion:

Liquid paraffin 6 g

Liquid lanolin 3 g - Arlacel 165 (marketed by Atlas) 6 g

Tween 60 (marketed by Atlas) 2 g

Cetyl alcohol 1.2 g

Stearic acid 2.5 g

Retinyl palmitate 0.5 g - Volatile silicone oil 10 g

Triethanolamine 0.1 g

Preservative 0.3 g

Antioxidants 0.3 g

Adenosine 0.3 g - Gingeng extract 5 g

Sage extract (Salvia officinalis L) 1 g

Demineralized water qs 100 g

2 / Liposome cream:

Sunflower oil 35 g

Cetyl alcohol 4 g B-sitosterol 4 g

Diketyl phosphate 0.5 g

Preservative 0.3 g

Carbopol 981 (marketed by Goodrich) 0.2 g - Triethanolamine 0.2 g

Sphingosine 0.05 g

Adenosine 1 g

Ginseng extract 0.5 g

Fragon glycine (Ruscus aculeatus) 1 g - Demineralized water qs 100 g

The above embodiments can advantageously be used on the breasts in order to increase the volume. The following embodiment can be applied to all zones whose volume must be increased:

W / O emulsion:

Protein (sold by Goldschmidt) 19 g

Glycerin 3 g

Vaseline oil 8 g - Mg sulfate 0.5 g

Adenosine 0.5 g

Ginseng extract 3 g

Orthosifon extract (Ortosifon stamincus) 1 g

Retinyl palmitate 0.02 g - Preservative 0.2 g

Demineralized water qs 100 g

According to the invention, one embodiment of the product with lipolytic property contains:

Acrylate C10-30 0.50 g Methylsilanol carboxymethyl 8.00 g

Ethoxydiglycol 5.00 g

Salicylic acid 0.444 g

Caffeine 2.20 g - Enteromorphia compressa extract 1.00 g

Carbomer 0.126 g

Butylene glycol 0.24 g

EDTA 0.005 g

Preservative 0.30 g - Macadamia oil 0.5 g

Hydrogenated lecithin 0.09 g

Cyclomethicone 0.20 g

TEA 99% 1.12 g

Ginkgo biloba extract 0.75 g - Chrysanthellum indicum extract 0.05 g

Dyes 0.0001 g

Demineralized water qs 100 g

We cite below other examples of realization of the lipolytic product.

Example 1:

- Carboxypolymethylene 0.40 g

Diethanolamine cetyl phosphate 1.50 g

Octyl dodecanol 5.50 g

Cetyl alcohol 1.00 g

Mineral oil 3.00 g - Stearic acid 1.00 g

Ethoxylated steryl alcohol (20E) 0.30 g

Keto-stearyl alcohol 1.50 g Preservative 0.30 g

Macadamia oil 1.00 g

Triethanolamine 0.60 g

Cyclomethicone 13.0 g - Dimethicone copolyol 1.00 g

Phenyl Trimethicone 2.00 g

Ginkgo biloba extract 0.75 g

Seaweed extract 1.00 g

Caffeine 2.00 g - Methylsilanol carboxymethyl theophylline alginate 8.00 g

Demineralized water qs 100 g

Example 2:

O / W gel emulsion:

Carbopol 981 (marketed by Goodrich) 0.6 g

Ethyl alcohol 15 g

Volatile silicone oil 3 g

Purcellin oil 7 g - Preservative 0.3 g

Anhydrous caffeine 1 g

Perfume 0.4 g

Seaweed extract 2 g

0.2 g triethanolamine - Chrysanthemum indicum extract 1 g

Demineralized water qs 100 g

Example 3:

Liposome cream:

Sunflower oil 35 g

Cetyl alcohol 4 g B-sitosterol 4 g

Diketyl phosphate 0.5 g

Preservative 0.3 g

Perfume 0.6 g - Carbopol 981 (marketed by Goodrich) 0.2 g

0.2 g triethanolamine

Sphingosine 0.05 g

Caffeine 3 g

Methylsilanol carboxymethyl theophylline alginate 4 g - Ginkgo biloba 2 g

Demineralized water qs 100 g

The above embodiments can advantageously be used on the hips in order to reduce the volume. The following embodiment can be applied to any zone whose volume must be reduced:

EIH emulsion:

Protein (marketed by Goldschmidt) 19 g - Glycerin 3 g

Vaseline oil 8 g

Mg sulfate 0.5 g

Perfume 0.8 g

Caffeine 0.5 g - Enteromorpha compressa extract 2 g

Preservative 0.2 g

Demineralized water qs 100 g

The effectiveness of the examples according to the invention was analyzed by a sensory study on analog scales for four weeks with 114 subjects, on the improvement of the shape and general aesthetics of the bust and hips. This self-assessment uses a scoring technique commonly used in this type of In Use Test: the scoring technique on an unstructured analog scale.

This method allows each volunteer to position themselves, for each of the criteria concerned, on a continuous analog scale, unstructured, materialized by a 10 cm line, and comprised between two opposite qualitative criteria.

The 114 volunteers complete these analog scales before the start of the study (T0) and again after four weeks of using the product (T4s).

The products are distributed to volunteers who apply them once or twice a day, for four weeks at the level of the bust for the lipogenetic product and at the level of the thighs, belly and hips for the lipolytic product. They are instructed to wash their hands thoroughly between the application of the two products.

The results are expressed by the average of the measurements in cm of the position of the criterion on the given axis.

In the present case, the following seven criteria will be taken into account: volume, firmness, hold, slimming, stomach, silhouette and cellulite.

Student's t-test in pairs was used in the statistical study. Breast test

Test for the Hips

S: Significant.

The embodiment of the invention described below is particularly preferred for the treatment of disproportionate breasts (lipolytic product on the large breast and lipogenetic product on the small breast).

Product to apply on the largest breast W / O emulsion:

Protein (marketed by Goldschmidt) 19 g

Glycerin 3 g - Vaseline oil 8 g

Mg sulfate 0.5 g

Perfume 0.8 g

Caffeine 2 g

Chrysanthellium indicum extract 3 g - Preservative 0.2 g

Demineralized water qs 100 g

Product to be applied to the smallest breast

W / O emulsion:

Protein (marketed by Goldschmidt) 19 g

Glycerin 3 g

Vaseline oil 8 g - Mg sulfate 0.5 g

Adenosine 0.02 g

Ginseng extract 4 g

Retinyl palmitate 0.001g

Preservative 0.2 g - Demineralized water qs 100 g

Using advice :

• Wash your hands well between the application of the two products on each of the two breasts.

Let the two emulsions penetrate well to avoid any mixing between the products.

Claims

1.) A method of cosmetic treatment of the body intended to improve the silhouette, characterized in that one applies, on the one hand, to a first zone whose volume one wants to reduce (for example the hips or the most voluminous breast in the case of disproportionate breasts), a product endowed with lipolytic properties in order to cause a lipolysis of the fats contained in the adipocytes of the concerned tissues (hips, ...), and, on the other hand, on a second zone which one wants increase the volume (for example the breast or breasts), a product endowed with lipogenetic properties so as to carry out a capture and a fixation, in said second zone, of the fats released by the application of the lipolytic product.

2.) A method of cosmetic treatment of the body according to claim 1, intended for developing the bust, characterized in that one applies on the one hand to an adipose area of the body, a product endowed with lipolytic properties in order to cause lipolysis fats contained in the adipocytes of the tissues of the zone concerned, and on the other hand, on the part or parts of the bust which it is desired to develop, a product endowed with lipogenetic properties or with an ability to capture the fats released by applying the lipolytic product and fixing them in said parts of the bust

3.) A method of cosmetic treatment of the body intended to improve the silhouette according to claim 1, characterized in that one applies:

- on the area whose volume is to be reduced (hips, most voluminous breast in the case of disproportionate breasts, ...) on the one hand, a lipolytic product containing xanthines, and in particular caffeine or even nicotinate alpha-tocopherol, cola extract, carnitine, vitamin E and its acetate, alpha 2 receptor blockers like Ginkgo biloba, NPY receptor inhibitors like extract Enteromorpha compressa and any other lipolytic agent capable of releasing fat from adipocytes such as oily plant extracts (Hedera helix, Arnica montana L, Rosmarinus officinalis, Calendule officinalis, Salvia officinalis L, Hypericum perforatum, Ruscus aculeatus L, Filipendula ulmaria L, Ortosifon stamincus benth, algae extract), water-soluble plant extracts (from algae, Hedera helix, Betula alba), hydro-alcoholic plant extracts including the hydroalcoholic extract of cola nuts (Cola Nipida)

- on the area whose volume is to be increased (breasts, etc.) on the other hand a lipogenetic product containing adenosine and / or vitamin A and / or Pro-retinol and Ginseng and / or insulin-like substances and / or any IGF-type factor (insulin growth factor), capable of retaining fat in breast adipocytes.

4.) Method of cosmetic treatment of the body intended to develop the bust according to claim 2 characterized in that one applies:

- on the adipose area of the body on the one hand, a lipolytic product containing xanthines, and in particular caffeine or even alpha-tocopherol nicotinate, cola extract, carnitine, vitamin E and its acetate, alpha 2 receptor blockers such as Ginkgo biloba, NPY receptor blockers such as

Enteromorpha compressa as well as any other lipolytic agent capable of releasing the fat from adipocytes such as oily plant extracts (Hedera helix, Arnica montana L, Rosmarinus officinalis,

Calendule officinalis, Salvia officinalis L, Hypericum perforatum, Ruscus aculeatus L, Filipendula ulmaria L, Ortosifon stamincus benth, algae extract), water-soluble plant extracts (derived from algae, Hedera helix, Betula alba), hydro- alcoholics including hydroalcoholic extract of cola nuts (Cola Nipida) - on the part or parts of the bust that one wishes to develop on the other hand, a lipogenetic product containing adenosine and / or vitamin A and / or Pro-retinol and Ginseng and / or insulin substances -like and / or any IGF type factor (insulin growth factor), capable of retaining fat in breast fat cells.

5.) A method of cosmetic treatment of the body according to any one of claims 1 to 4 characterized in that the lipogenetic product and / or the lipolytic product is applied in the form of an oil in water or water in oil emulsion having l appearance of a cream or milk, or in the form of a gel, or lipid vesicles consisting of ionic lipids (liposomes) or nonionic lipids

6.) Binary cosmetic composition for implementing the method according to any one of claims 1 to 5, characterized in that it consists on the one hand, of a product endowed with lipolytic properties intended to be applied to an adipose zone of the body, and on the other hand, of a product endowed with lipogenetic properties or an capacity to capture fats and to fix them, intended to be applied on the part or parts of the body which one wishes develop

7.) Cosmetic composition according to claim 6, characterized in that the lipolytic product contains xanthines, and in particular caffeine or also alpha-tocopherol nicotinate, cola extract, carnitine, vitamin E and its acetate , alpha 2 receptor blockers like

Ginkgo biloba, NPY receptor inhibitors like Enteromorpha compressa extract as well as any other lipolytic agent capable of releasing fat from adipocytes such as oily plant extracts (Hedera helix, Arnica montana L, Rosmarinus officinalis, Calendule officinalis, Salvia officinalis L, Hypericum perforatum, Ruscus aculeatus L,

Filipendula ulmaria L, Ortosifon stamincus benth, algae extract), water-soluble plant extracts (from algae, Hedera helix, Betula alba), hydro-alcoholic plant extracts including hydro-alcoholic extract of cola nuts (Cola Nipida)

8.) Cosmetic composition according to claim 6, characterized in that the lipogenetic product contains adenosine and / or vitamin A and / or

Pro-retinol and Ginseng and / or insulin-like substances and / or any IGF-type factor (insulin growth factor), capable of retaining fat in breast fat cells.

9.) Cosmetic composition according to any one of claims 6 to 8, characterized in that it is in the form of an oil in water or water in oil emulsion having the appearance of a cream or a milk, or in the form of a gel, or lipid vesicles consisting of ionic lipids (liposomes) or nonionic lipids